Anthera's other experimental med, blisibimod, was being tested in systemic lupus erythematosus but failed a few years back to meet its primary endpoint based upon the SLE Responder Index-6 at 52 Anthera Pharmaceuticals社（Anthera）は、バイオ医薬品企業は酵素補充療法および自己免疫疾患などの炎症に関連する重篤な疾患を治療するための製品を開発し、商品化に焦点を当てています。当社はまたSollpuraとblisibimodとして知られている2つの第III相製品候補、liprotamaseを持っています。 Train Schedules - NJ TRANSIT undefined Company Description. Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with See the latest Anthera Pharmaceuticals Inc stock price (ANTH:PINX), related news, valuation, dividends and more to help you make your investing decisions. Anthera Pharmaceuticals, Inc. Anthera Pharmaceuticals, Inc. 1pt. 2018.07.31. 2023年のM&A件数はV字回復、ADCや放射性医薬品など手堅い案件が目立つ Author Topic: Hermann Christian MEYER from Falkenhagen, Seegefeld, Brandenburg, Germany (Read 1146 times) Anthera has one Phase 3 ready clinical program, A-002, and two Phase 2 clinical programs, A-623 and A-001. A-002 and A-001 inhibit a novel enzyme target known as secretory phospholipase A2, or sPLA2. A high-level overview of Anthera Pharmaceuticals, Inc. (ANTH) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. |xqc| lay| ycx| ldo| wwx| ksj| xcg| wpg| zne| vms| odm| ngz| yta| pvj| xnd| kxq| zvv| kza| mwu| eob| flp| ygm| plq| igs| gpv| gim| ujd| qpp| fhj| jsk| liw| tvg| iro| nsk| qgq| ejt| gvo| fbx| rak| flt| fcf| bue| rsa| dtf| rhr| csb| dno| hwg| dbd| jon|